Morningstar Investor review

Morningstar Investor is a research subscription first and a portfolio tracker second, and its price reflects that. The product page describes three parts: independent analysis and ratings, screening for investments that fit your risk tolerance and diversification needs, and portfolio insights tailored to your holdings. The yearly plan costs $249, which works out to $20.75 a month and saves 41% over the $34.95 monthly plan. A free trial runs until 11:59 PM CT seven days after it begins, and only first-time subscribers qualify. There is one plan, so everyone gets the same tools. For a fund or ETF investor who wants an outside view of what they own, ratings next to holdings are the reason to pay. For someone who only wants to log trades and see returns, the cheaper trackers on this list do that job for a fraction of the cost.

Who it is for

fund and ETF investors who want analyst ratings

Price

$249 per year (about $20.75 a month) or $34.95 monthly; 7-day free trial.

Yearly $249 $20.75/mo
Quoted from the vendor pricing page on November 14, 2026.

Key features

• Independent analyst research and ratings on holdings
• Screeners for risk tolerance and diversification needs
• Portfolio insights tailored to your holdings and preferences
• Yearly plan saves 41% over monthly billing
• 7-day free trial for first-time subscribers

Strengths and weaknesses

• Strength: Ratings and analysis come from Morningstar's own analysts
• Strength: Yearly plan cuts the monthly cost to $20.75
• Strength: One plan, so there are no feature tiers to compare
• Weakness: No free plan; the trial ends seven days after it starts
• Weakness: Monthly billing costs $34.95
• Weakness: Built for research, so it costs more than tracking-only apps

Key facts

• Yearly: $249
• Monthly: $34.95
• Trial: 7 days, first trial only
• Plans: One

Where it ranks

Morningstar Investor is No. 7 in our Best Portfolio Trackers verdict.